Blackthorn Therapeutics Stock

blackthornrx.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $130.3MM

BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) disorders.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Blackthorn Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Blackthorn Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Blackthorn Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Edward Roberts Ph.D
Scientific Co-Founder
Paul Berns
Executive Chairman
William Martin Ph.D
Co-Founder, President, Chief Executive Officer & Board Member
Jane Tiller MD
Chief Medical Officer
Monique Levy
Chief Strategy Officer
Hugh Rosen Ph.D
Scientific Co-Founder

Board Members

John MacPhee
Julie Sunderland
Biomatics Capital
Matthew Fust
William Martin Ph.D
Brian Chee
Polaris Partners
Lori Hu
Vertex Ventures HC
Asish Xavier Ph.D
Johnson & Johnson Innovation - JJDC
Kristina Burow
ARCH Venture Partners
Paul Berns

Blackthorn Therapeutics’ stock FAQs


Can you buy Blackthorn Therapeutics’ stock?

As Blackthorn Therapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Blackthorn Therapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge's Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Blackthorn Therapeutics’ stock?

To invest in a private company like Blackthorn Therapeutics’ through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge's marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Blackthorn Therapeutics’ stock?

Yes, you may be able to sell your Blackthorn Therapeutics’ stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Blackthorn Therapeutics’ stock?

If you hold private company shares of Blackthorn Therapeutics’ - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Blackthorn Therapeutics’ on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Blackthorn Therapeutics’ a public company?

No, Blackthorn Therapeutics’ is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Blackthorn Therapeutics’ stock price?

Blackthorn Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Blackthorn Therapeutics’ private market stock price with Forge Data.

What is Blackthorn Therapeutics’ stock ticker symbol?

Blackthorn Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

BlackThorn Therapeutics Appoints William J. Martin, Ph.D., as Chief Executive Officer to Lead Next Stage of Growth

BlackThorn Therapeutics, Inc., today announced the promotion of company co-founder and seasoned CNS drug discovery and development expert, William J.

Neurobehavioral health company BlackThorn pulls in $76 million from GV to treat mental disorders – TechCrunch

There are numerous challenges to finding effective treatments for mental disorders. However, BlackThorn Therapeutics, a neurobehavioral health company using machine learning to create personalized medicine for mental health, is betting its technological approach to finding drugs that work will put …
Updated on: Jul 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.